Vir Biotechnology, Inc. (VIR)
USD 6.16
(1.32%)
USD 6.16
(1.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 767.72 Million USD | 20.61% |
| 2022 | 601.08 Million USD | 0.11% |
| 2021 | 600.45 Million USD | 64.86% |
| 2020 | 364.22 Million USD | 103.83% |
| 2019 | 178.69 Million USD | 49.46% |
| 2018 | 119.56 Million USD | 46.44% |
| 2017 | 81.64 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 128.12 Million USD | 22.87% |
| 2024 Q3 | 220.92 Million USD | 82.34% |
| 2024 Q1 | 104.28 Million USD | -18.93% |
| 2023 Q2 | 202.44 Million USD | 7.58% |
| 2023 FY | 724.96 Million USD | 20.61% |
| 2023 Q4 | 128.62 Million USD | -29.56% |
| 2023 Q3 | 182.59 Million USD | -9.8% |
| 2023 Q1 | 188.17 Million USD | 13.16% |
| 2022 Q3 | 154.21 Million USD | -0.26% |
| 2022 Q2 | 154.61 Million USD | 22.75% |
| 2022 Q1 | 125.96 Million USD | -30.46% |
| 2022 FY | 601.08 Million USD | 0.11% |
| 2022 Q4 | 166.29 Million USD | 7.83% |
| 2021 FY | 600.45 Million USD | 64.86% |
| 2021 Q4 | 181.12 Million USD | 22.17% |
| 2021 Q3 | 148.26 Million USD | 32.58% |
| 2021 Q2 | 111.82 Million USD | -29.77% |
| 2021 Q1 | 159.23 Million USD | 46.49% |
| 2020 Q3 | 87.8 Million USD | -7.89% |
| 2020 Q2 | 95.32 Million USD | 31.66% |
| 2020 FY | 364.22 Million USD | 103.83% |
| 2020 Q1 | 72.39 Million USD | 12.89% |
| 2020 Q4 | 108.7 Million USD | 23.81% |
| 2019 Q3 | 47.91 Million USD | 33.64% |
| 2019 FY | 178.69 Million USD | 49.46% |
| 2019 Q1 | 30.78 Million USD | 14.87% |
| 2019 Q4 | 64.13 Million USD | 33.84% |
| 2019 Q2 | 35.85 Million USD | 16.46% |
| 2018 Q4 | 26.8 Million USD | -22.22% |
| 2018 Q1 | 8 Million USD | 0.0% |
| 2018 FY | 119.56 Million USD | 46.44% |
| 2018 Q2 | 8 Million USD | 0.0% |
| 2018 Q3 | 34.46 Million USD | 330.48% |
| 2017 FY | 81.64 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Absci Corporation | 73.66 Million USD | -942.163% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -138.602% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 57.35% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -7625.372% |
| Apollomics, Inc. | 54.14 Million USD | -1318.027% |
| 180 Life Sciences Corp. | 13.47 Million USD | -5596.309% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -2346.76% |
| Bicycle Therapeutics plc | 216.92 Million USD | -253.915% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -806.228% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -346.603% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1533.238% |
| Chimerix, Inc. | 93.38 Million USD | -722.067% |
| CRISPR Therapeutics AG | 463.49 Million USD | -65.638% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -2176.21% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -559.253% |
| Fortress Biotech, Inc. | 200.19 Million USD | -283.486% |
| Fortress Biotech, Inc. | 200.19 Million USD | -283.486% |
| Gritstone bio, Inc. | 148.37 Million USD | -417.422% |
| Allakos Inc. | 196.05 Million USD | -291.582% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -1301.051% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -438.891% |
| Cytokinetics, Incorporated | 173.61 Million USD | -342.204% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -2865.888% |
| Innoviva, Inc. | 132.15 Million USD | -480.928% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -9880.445% |
| NLS Pharmaceutics AG | 11.8 Million USD | -6402.21% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -504.209% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -5953987.172% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -648.572% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -763.907% |
| ImmuCell Corporation | 9.61 Million USD | -7882.646% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -386.471% |
| Incyte Corporation | 1.19 Billion USD | 35.513% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -479.17% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -11309.582% |
| Mustang Bio, Inc. | 48.5 Million USD | -1482.895% |
| MiMedx Group, Inc. | 229.72 Million USD | -234.188% |
| MEI Pharma, Inc. | 34.78 Million USD | -2107.043% |
| MacroGenics, Inc. | 217.21 Million USD | -253.438% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -8593.235% |
| Mereo BioPharma Group plc | 35.84 Million USD | -2041.956% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -4190.734% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -378.211% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -346.738% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -3225.105% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -4732.683% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -7364.463% |
| NextCure, Inc. | 67.63 Million USD | -1035.059% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -1319.601% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -2493.123% |
| Onconetix, Inc. | 34.9 Million USD | -2099.303% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -5923.223% |
| Opthea Limited | 191.96 Million USD | -299.922% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1186.542% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -27801.01% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1683.519% |
| Precigen, Inc. | 84.18 Million USD | -811.987% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -957.961% |
| Prime Medicine, Inc. | 186.63 Million USD | -311.34% |
| PureTech Health plc | 144.59 Million USD | -430.938% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -195.665% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 72.73% |
| Replimune Group, Inc. | 234.77 Million USD | -227.005% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -8768.543% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -489.362% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -3853.546% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -53.924% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3058.483% |
| Sesen Bio, Inc. | 78.38 Million USD | -879.472% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -235.718% |
| Solid Biosciences Inc. | 104.31 Million USD | -635.963% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -233.858% |
| SciSparc Ltd. | 9.01 Million USD | -8419.809% |
| Sutro Biopharma, Inc. | 243 Million USD | -215.922% |
| TG Therapeutics, Inc. | 198.47 Million USD | -286.809% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -532.352% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -10189.773% |
| Travere Therapeutics, Inc. | 472 Million USD | -62.652% |
| UroGen Pharma Ltd. | 138.88 Million USD | -452.762% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -987.515% |
| XOMA Corporation | 46.46 Million USD | -1552.326% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -203.985% |
| AbCellera Biologics Inc. | 275.23 Million USD | -178.936% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1252.596% |
| Cassava Sciences, Inc. | 105.95 Million USD | -624.558% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -5419.337% |
| Precision BioSciences, Inc. | 92.46 Million USD | -730.3% |
| Dyadic International, Inc. | 9.15 Million USD | -8287.911% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -9128.513% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -3349.962% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -2486.483% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -485.184% |
| IGM Biosciences, Inc. | 265.59 Million USD | -189.061% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -614.012% |
| Acelyrin, Inc. | 422.06 Million USD | -81.897% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -4179.614% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -810.451% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -11304.135% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -213.35% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -2394.947% |
| Senti Biosciences, Inc. | 94.7 Million USD | -710.644% |
| Mesoblast Limited | 5.9 Million USD | -12907.794% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -214.482% |
| ChromaDex Corporation | 56.37 Million USD | -1261.713% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -2203.385% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -281.732% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -9446.493% |
| Seer, Inc. | 110.49 Million USD | -594.832% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -355.793% |
| Novavax, Inc. | 779.12 Million USD | 1.464% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -4793.119% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -202.2% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1369.292% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -210.644% |
| Celcuity Inc. | 66.23 Million USD | -1059.167% |
| ContextLogic Inc. | 387 Million USD | -98.377% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -357.447% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -2244.47% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 76.419% |
| Amarin Corporation plc | 272.35 Million USD | -181.88% |
| AnaptysBio, Inc. | 181.56 Million USD | -322.828% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -2558.494% |
| Aptorum Group Limited | 10.56 Thousand USD | -7265847.378% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -592.469% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -72.236% |
| Ardelyx, Inc. | 169.93 Million USD | -351.767% |
| Celularity Inc. | 215.05 Million USD | -256.983% |
| Omeros Corporation | 94.75 Million USD | -710.25% |
| Humacyte, Inc. | 23.49 Million USD | -3167.311% |
| Immunocore Holdings plc | 308.04 Million USD | -149.227% |
| IO Biotech, Inc. | 91.44 Million USD | -739.561% |
| GT Biopharma, Inc. | 13.57 Million USD | -5554.979% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -928.288% |
| Summit Therapeutics Inc. | 87.68 Million USD | -775.533% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -2505.178% |
| Pulmatrix, Inc. | 22.03 Million USD | -3383.619% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -39.189% |
| Evogene Ltd. | 27.79 Million USD | -2662.576% |
| CorMedix Inc. | 48.95 Million USD | -1468.126% |
| BioLineRx Ltd. | 50.8 Million USD | -1411.2% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -2152.369% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -2244.899% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 41.478% |
| scPharmaceuticals Inc. | 65.17 Million USD | -1077.882% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -576.59% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -108.273% |
| NLS Pharmaceutics AG | 11.8 Million USD | -6402.21% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3058.483% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -344.103% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -1952.288% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -2886.308% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -521.369% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -824.374% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -1345.082% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -8982.503% |
| Daré Bioscience, Inc. | 33.6 Million USD | -2184.242% |
| bluebird bio, Inc. | 240.23 Million USD | -219.574% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 56.037% |
| DBV Technologies S.A. | 92.16 Million USD | -733.03% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -213.153% |
| Galecto, Inc. | 35.62 Million USD | -2054.883% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -1971.336% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -1136.623% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -249.233% |
| GlycoMimetics, Inc. | 39.28 Million USD | -1854.217% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -159.61% |
| ADMA Biologics, Inc. | 66.58 Million USD | -1052.975% |
| Clene Inc. | 41.07 Million USD | -1769.16% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -118.073% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1366.346% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -5227.551% |
| Soligenix, Inc. | 7.79 Million USD | -9748.56% |
| Century Therapeutics, Inc. | 56.07 Million USD | -1269.193% |
| Kura Oncology, Inc. | 165.8 Million USD | -363.029% |
| Surrozen, Inc. | 18.55 Million USD | -4038.652% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -570.457% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -30836.006% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -612.845% |
| Autolus Therapeutics plc | 196.72 Million USD | -290.248% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -806.859% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -3860.79% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -409.991% |
| GRI Bio, Inc. | 11.33 Million USD | -6675.993% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -10780.847% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -847.078% |
| INmune Bio, Inc. | 29.89 Million USD | -2467.969% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -344.916% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1804.336% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4704.447% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -9223.846% |
| Jaguar Health, Inc. | 42.01 Million USD | -1727.252% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -4777.028% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -1136.304% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -2246.691% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -178.469% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -154.675% |
| Verastem, Inc. | 92.08 Million USD | -733.717% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -313.364% |
| Histogen Inc. | 14.27 Million USD | -5279.204% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -4683.856% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -1.808% |
| Surrozen, Inc. | 18.55 Million USD | -4038.652% |
| Organovo Holdings, Inc. | 14.91 Million USD | -5047.301% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -14982.208% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -9958.113% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -330.974% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1484.628% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -4896.039% |
| Kronos Bio, Inc. | 128.11 Million USD | -499.229% |
| Turnstone Biologics Corp. | 78.33 Million USD | -880.01% |
| Synaptogenix, Inc. | 8.31 Million USD | -9134.225% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -5163.403% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -480.836% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -203.379% |
| Exelixis, Inc. | 1.58 Billion USD | 51.618% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -230.842% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 10.229% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1014.884% |
| ESSA Pharma Inc. | 32.13 Million USD | -2289.113% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -4592.603% |
| Avid Bioservices, Inc. | 25.99 Million USD | -2853.224% |
| Insmed Incorporated | 949.26 Million USD | 19.124% |
| MediWound Ltd. | 18.86 Million USD | -3968.9% |
| OmniAb, Inc. | 83.89 Million USD | -815.096% |
| Alector, Inc. | 248.8 Million USD | -208.567% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -227.654% |
| Zai Lab Limited | 547.47 Million USD | -40.229% |
| AlloVir, Inc. | 180.93 Million USD | -324.312% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -92.578% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -593.013% |
| Aura Biosciences, Inc. | 84.99 Million USD | -803.296% |
| Immunic, Inc. | 99.22 Million USD | -673.732% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -382.806% |
| Veracyte, Inc. | 357.93 Million USD | -114.487% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 91.485% |
| FibroGen, Inc. | 398.11 Million USD | -92.84% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -5302.674% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -195.931% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -11045.847% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -10673.911% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -2867.263% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -142.533% |
| Fortrea Holdings Inc. | 457.3 Million USD | -67.881% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -1314.422% |
| XBiotech Inc. | 37.51 Million USD | -1946.708% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1014.884% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -353.529% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -1927.305% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -3617.952% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -440.416% |
| Agenus Inc. | 78.18 Million USD | -881.953% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -674.888% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -593.414% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 19.883% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -2561.536% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -78.274% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -3341.408% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -380.465% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -13780.441% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -2915.515% |
| Lantern Pharma Inc. | 17.87 Million USD | -4194.32% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1685.395% |
| Ainos, Inc. | 12.95 Million USD | -5827.121% |
| Pluri Inc. | 22.48 Million USD | -3315.125% |
| Prothena Corporation plc | 282.4 Million USD | -171.85% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -283.818% |
| Rallybio Corporation | 78.93 Million USD | -872.635% |
| Kodiak Sciences Inc. | 277.32 Million USD | -176.834% |
| Cue Biopharma, Inc. | 19.54 Million USD | -3828.564% |
| MeiraGTx Holdings plc | 151.07 Million USD | -408.161% |
| Annexon, Inc. | 143.72 Million USD | -434.166% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -3251.172% |
| Moderna, Inc. | 6.39 Billion USD | 87.993% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -22546.608% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -783.808% |
| Blueprint Medicines Corporation | 722.86 Million USD | -6.206% |
| Immix Biopharma, Inc. | 16.14 Million USD | -4656.302% |
| CalciMedica, Inc. | 21.81 Million USD | -3418.907% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -435.702% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -348.186% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -323.451% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -160.297% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -2120.448% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -958.18% |
| Nutriband Inc. | 5.73 Million USD | -13288.836% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1660.301% |
| Vor Biopharma Inc. | 126.03 Million USD | -509.128% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 35.441% |
| Alkermes plc | 996.24 Million USD | 22.939% |
| ProKidney Corp. | 151.52 Million USD | -406.672% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -935.012% |
| Arcellx, Inc. | 200.19 Million USD | -283.478% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -24.99% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -409.436% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -1916.495% |
| Atai Life Sciences N.V. | 125.78 Million USD | -510.343% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -840.38% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -843.041% |
| MediciNova, Inc. | 10.9 Million USD | -6943.132% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -495.963% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -10475.349% |
| GeoVax Labs, Inc. | 6.02 Million USD | -12648.222% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -61.164% |
| Biomea Fusion, Inc. | 126.13 Million USD | -508.649% |
| RenovoRx, Inc. | 11.39 Million USD | -6636.75% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -301.76% |
| Geron Corporation | 70.44 Million USD | -989.877% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2683.409% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -474.684% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -217.027% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -192.969% |
| Royalty Pharma plc | 862.4 Million USD | 10.979% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -269.107% |
| Imunon, Inc. | 20.31 Million USD | -3679.931% |
| BioAtla, Inc. | 129.68 Million USD | -491.979% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -804.072% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1738.498% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -269.43% |
| Structure Therapeutics Inc. | 102.77 Million USD | -646.991% |
| 89bio, Inc. | 151.2 Million USD | -407.738% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -590.576% |
| aTyr Pharma, Inc. | 12.97 Million USD | -5815.094% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -640.642% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -201.346% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -9234.193% |
| Akari Therapeutics, Plc | 16.8 Million USD | -4468.13% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -33661.219% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -156.49% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -344.105% |
| Liquidia Corporation | 87.98 Million USD | -772.568% |
| Entera Bio Ltd. | 8.86 Million USD | -8565.011% |
| GH Research PLC | 41.22 Million USD | -1762.404% |
| Vericel Corporation | 142.04 Million USD | -440.496% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -3305.429% |
| Xencor, Inc. | 306.97 Million USD | -150.09% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -15461.032% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4704.447% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -3646.824% |
| Vaxcyte, Inc. | 468.04 Million USD | -64.028% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1549.521% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -300.279% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -11309.582% |
| Portage Biotech Inc. | 18.19 Million USD | -4118.474% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -10475.349% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -631.434% |
| OncoCyte Corporation | 25.63 Million USD | -2894.578% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -12494.644% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -6600.846% |
| Purple Biotech Ltd. | -22.46 Million USD | 3517.101% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -2533.056% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -2387.832% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -204.068% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -4558.495% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -2490.935% |
| United Therapeutics Corporation | 885.1 Million USD | 13.262% |
| HilleVax, Inc. | 133.34 Million USD | -475.74% |
| Silo Pharma, Inc. | 3.92 Million USD | -19475.426% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -19375.156% |
| Pharming Group N.V. | 225.49 Million USD | -240.466% |
| Tharimmune, Inc. | 9.45 Million USD | -8019.536% |
| Genprex, Inc. | 31.06 Million USD | -2371.687% |
| Apogee Therapeutics, Inc. | 93 Million USD | -725.479% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -309.394% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -834.011% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -100255.556% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -13994.573% |
| OKYO Pharma Limited | 8243.57 USD | -9312855.431% |
| Savara Inc. | 15.74 Million USD | -4775.961% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -4297.777% |
| Curis, Inc. | 58.35 Million USD | -1215.603% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -14975.539% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -2741.092% |
| BeiGene, Ltd. | 3.28 Billion USD | 76.641% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -399.649% |
| Erasca, Inc. | 141.52 Million USD | -442.462% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -16858.79% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -16858.79% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1701.779% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -5244.007% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -1050.987% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1668.37% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -268.866% |
| Adicet Bio, Inc. | 152.03 Million USD | -404.953% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -79.52% |
| Aditxt, Inc. | 25.95 Million USD | -2858.371% |
| Adagene Inc. | 41.83 Million USD | -1735.274% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -10402.185% |
| Quantum-Si incorporated | 111.65 Million USD | -587.558% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -5166.375% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -2043.152% |
| Compugen Ltd. | 43.97 Million USD | -1645.969% |
| Generation Bio Co. | 144.46 Million USD | -431.415% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -824.63% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -787.948% |
| Invivyd, Inc. | 205.75 Million USD | -273.123% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -963.928% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -8085.954% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -920.172% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -7363.012% |
| 2seventy bio, Inc. | 289.88 Million USD | -164.834% |
| Instil Bio, Inc. | 85.78 Million USD | -794.935% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -5894.12% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -67565.568% |
| GeoVax Labs, Inc. | 6.02 Million USD | -12648.222% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -1990.057% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -640.314% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -350.863% |
| Evaxion Biotech A/S | 22.27 Million USD | -3347.328% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -466.399% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -226.853% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -860.31% |
| Cingulate Inc. | 22.75 Million USD | -3273.231% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 10347.197% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1618.763% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -1136.782% |
| Clearmind Medicine Inc. | 8.74 Million USD | -8682.625% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -813.17% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -26075.381% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -661.423% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -101.768% |
| ImmunityBio, Inc. | 362.87 Million USD | -111.568% |
| Korro Bio, Inc. | 84.53 Million USD | -808.179% |
| Kineta, Inc. | 21.15 Million USD | -3528.852% |
| BioVie Inc. | 31.95 Million USD | -2302.864% |
| Codexis, Inc. | 66.51 Million USD | -1054.154% |
| Celularity Inc. | 215.05 Million USD | -256.983% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -4616.884% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -238.768% |
| Virax Biolabs Group Limited | 6.54 Million USD | -11626.174% |
| Cibus, Inc. | 320.3 Million USD | -139.684% |
| IN8bio, Inc. | 30.33 Million USD | -2430.639% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -501.704% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -119856.25% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 1.522% |
| Eyenovia, Inc. | 25.4 Million USD | -2921.753% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -447.14% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -13702.949% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1589.339% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -870.164% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1572.593% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -254.751% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -7610.355% |
| Moolec Science SA | 52.75 Million USD | -1355.377% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -1155.717% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1549.592% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -716.098% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1483.81% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -8130.393% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -3292.708% |
| Humacyte, Inc. | 23.49 Million USD | -3167.311% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -858.069% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -5180.055% |
| Genelux Corporation | 24.33 Million USD | -3054.798% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -2163.125% |
| Notable Labs, Ltd. | 14.77 Million USD | -5097.833% |
| Immunovant, Inc. | 282.7 Million USD | -171.558% |
| Quantum-Si incorporated | 111.65 Million USD | -587.558% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -3509.912% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -652.578% |
| Acasti Pharma Inc. | 11.3 Million USD | -6693.381% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -3249.402% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1755.113% |
| PepGen Inc. | 84.76 Million USD | -805.693% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -3252.928% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -2245.936% |
| Immuneering Corporation | 58.41 Million USD | -1214.299% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -14982.208% |
| Belite Bio, Inc | 31.66 Million USD | -2324.277% |
| XOMA Corporation | 46.46 Million USD | -1552.326% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -1036.521% |
| Bionomics Limited | 17.89 Billion USD | 95.709% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2251.682% |
| uniQure N.V. | 285.08 Million USD | -169.294% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -10402.185% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -295.31% |
| Forte Biosciences, Inc. | 32.47 Million USD | -2263.888% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -9139.892% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -2511.737% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -13702.949% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -5302.674% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -8536.742% |
| Altimmune, Inc. | 30.55 Million USD | -2412.502% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -985.838% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2251.682% |
| Peak Bio, Inc. | 1249.13 USD | -61460276.422% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -935.78% |
| Benitec Biopharma Inc. | 22.38 Million USD | -3330.078% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -215.689% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -2589.696% |
| Zura Bio Limited | 62.63 Million USD | -1125.646% |
| PolyPid Ltd. | 21.04 Million USD | -3547.992% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -2589.696% |
| argenx SE | 1.53 Billion USD | 49.938% |
| Immunome, Inc. | 122.82 Million USD | -525.077% |
| Verona Pharma plc | 67.15 Million USD | -1043.269% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -2865.888% |
| Shattuck Labs, Inc. | 93.61 Million USD | -720.091% |
| CervoMed Inc. | 14.95 Million USD | -5032.584% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -8885.487% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1405.333% |
| Moolec Science SA | 52.75 Million USD | -1355.377% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -4567.434% |
| Design Therapeutics, Inc. | 78.19 Million USD | -881.865% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -782.021% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -6000.278% |
| Achilles Therapeutics plc | 75.25 Million USD | -920.158% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -26075.381% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -1279.476% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1408.913% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -1061.47% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -1318.47% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1590.678% |
| Beam Therapeutics Inc. | 554.19 Million USD | -38.529% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -208.955% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1485.249% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -721.284% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -819.106% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -5999.359% |
| NeurAxis, Inc. | 8.82 Million USD | -8603.125% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -70.229% |
| Lumos Pharma, Inc. | 38.66 Million USD | -1885.568% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -2796.79% |
| Palisade Bio, Inc. | 13.32 Million USD | -5663.664% |
| Nutriband Inc. | 5.73 Million USD | -13288.836% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -773.501% |
| Neurogene Inc. | 55.58 Million USD | -1281.214% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -8984.369% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -693.837% |
| Athira Pharma, Inc. | 125.46 Million USD | -511.895% |
| HCW Biologics Inc. | 21.02 Million USD | -3551.025% |
| XOMA Corporation | 46.46 Million USD | -1552.326% |
| Nektar Therapeutics | 190.9 Million USD | -302.152% |
| Arvinas, Inc. | 480 Million USD | -59.942% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -33661.219% |
| Merus N.V. | 200.49 Million USD | -282.914% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -642.799% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -2117.562% |
| Rezolute, Inc. | 70.38 Million USD | -990.713% |
| Clene Inc. | 41.07 Million USD | -1769.16% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -4587.372% |
| BeyondSpring Inc. | 24.86 Million USD | -2987.553% |
| Synlogic, Inc. | 58.53 Million USD | -1211.624% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -4190.856% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -16990.828% |
| Peak Bio, Inc. | 1249.13 USD | -61460276.422% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -1170.092% |
| Krystal Biotech, Inc. | 160.42 Million USD | -378.551% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -183.678% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -120.585% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -35496.416% |
| MannKind Corporation | 125.59 Million USD | -511.257% |
| Ikena Oncology, Inc. | 84.57 Million USD | -807.717% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -7858.122% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -756.821% |
| Gossamer Bio, Inc. | 183.75 Million USD | -317.786% |
| CohBar, Inc. | 12.38 Million USD | -6097.139% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1413.524% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2683.409% |
| Legend Biotech Corporation | 583.14 Million USD | -31.652% |
| Mural Oncology plc | 192.07 Million USD | -299.706% |
| Disc Medicine, Inc. | 91.12 Million USD | -742.491% |
| Champions Oncology, Inc. | 28.11 Million USD | -2631.128% |
| REGENXBIO Inc. | 321.15 Million USD | -139.048% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -14219.838% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -1276.928% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -1870.501% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -571.336% |
| Vaxart, Inc. | 90.72 Million USD | -746.196% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -8910.79% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1693.986% |
| Cellectis S.A. | 97.32 Million USD | -688.861% |
| Longeveron Inc. | 21.25 Million USD | -3512.8% |
| Repare Therapeutics Inc. | 167.35 Million USD | -358.732% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 43.584% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -914.899% |
| Revolution Medicines, Inc. | 498.76 Million USD | -53.924% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -11441.191% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1646.644% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -929.253% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -1002.492% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -6841.41% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 83.922% |
| Denali Therapeutics Inc. | 527.23 Million USD | -45.614% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -8768.543% |
| Veru Inc. | 101.34 Million USD | -657.508% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -3179.874% |
| Cingulate Inc. | 22.75 Million USD | -3273.231% |
| Passage Bio, Inc. | 108.38 Million USD | -608.301% |
| Context Therapeutics Inc. | 25.07 Million USD | -2961.986% |
| Exicure, Inc. | 14.07 Million USD | -5354.106% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -272.564% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1672.984% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -8265.432% |
| Nuvalent, Inc. | 149.49 Million USD | -413.553% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -9416.912% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -640.685% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -3479.281% |
| OmniAb, Inc. | 83.89 Million USD | -815.096% |
| Anew Medical, Inc. | 1.3 Million USD | -58917.205% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -2243.182% |
| Lipocine Inc. | 15.08 Million USD | -4990.935% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -1020.546% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -908.142% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1804.336% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -568.495% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -3329.771% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -15.595% |
| Ocugen, Inc. | 71.56 Million USD | -972.729% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -717.889% |
| Q32 Bio Inc. | 92.68 Million USD | -728.356% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -3525.767% |
| Alumis Inc. Common Stock | 158.17 Million USD | -385.364% |
| Equillium, Inc. | 50.6 Million USD | -1417.053% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -1130.202% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -5420.959% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -3969.523% |
| Dominari Holdings Inc. | 23.83 Million USD | -3120.978% |
| Edesa Biotech, Inc. | 9.22 Million USD | -8224.191% |
| vTv Therapeutics Inc. | 11.9 Million USD | -6347.636% |
| Bio-Techne Corporation | 563.03 Million USD | -36.353% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -87.796% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -185.657% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -480.388% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -5227.319% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -368.991% |
| Nkarta, Inc. | 131.65 Million USD | -483.152% |
| BioCardia, Inc. | 12.12 Million USD | -6233.801% |
| Iterum Therapeutics plc | 47.46 Million USD | -1517.342% |